According to a study published in the British Medical Journal (BMJ), long-term use of high-dose cyproterone acetate is significantly associated with a dose-dependent increased risk of meningioma in women.
This discovery emphasizes the importance of screening for meningiomas when using high-dose cyproterone acetate.